Major South Lake Union biotech landlord to be acquired for $8B

The San Diego-based real estate company that owns the South Lake Union building that houses biotech company Juno Therapeutics and the Center for Infectious Disease Research (formerly Seattle BioMed) is being acquired.

There are more changes ahead for the building that houses Seattle biotech Juno Therapeutics (Nasdaq: JUNO) and the Center for Infectious Disease Research.

San Diego-based life science real estate company BioMed Realty Trust (NYSE: BMR) will be acquired by Blackstone Group L.P. (NYSE: BX) in an $8 billion cash deal, according to a press release. That comes out to $23.75 per share, 10 percent more than the closing price of BioMed’s shares on Wednesday.

Continue here http://www.bizjournals.com/seattle/blog/health-care-inc/2015/10/major-south-lake-union-biotech-landlord-to-be.html

Comments are closed.